Literature DB >> 17228029

Galectin-3 stimulates preadipocyte proliferation and is up-regulated in growing adipose tissue.

Kohji Kiwaki1, Colleen M Novak, Daniel K Hsu, Fu-Tong Liu, James A Levine.   

Abstract

OBJECTIVE: Some cytokines and mediators of inflammation can alter adiposity through their effects on adipocyte number. To probe the molecular basis of obesity, this study determined whether galectin-3 was present in adipose tissue and investigated its effects on fat cell number. RESEARCH METHODS AND PROCEDURES: In the first study, obesity-prone C57BL/6J mice were fed with high-fat (58%) diet. Epididymal fat pads were collected at Day 0, Day 60, and Day 120 after the start of high-fat feeding.
RESULTS: Levels of adipocyte galectin-3 protein, determined using Western blot analysis, increased as the mice became obese. Galectin-3 mRNA and protein were then detected in human adipose tissue, primarily in the preadipocyte fraction. It was found that recombinant human galectin-3 stimulated proliferation of primary cultured preadipocytes as well as DNA synthesis through lectin-carbohydrate interaction. DISCUSSION: Galectin-3, which has been known to play a versatile role especially in immune cells, might play a role also in adipose tissue and be associated with the pathophysiology of obesity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17228029     DOI: 10.1038/oby.2007.526

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  25 in total

1.  Targeted inhibition of galectin 1 by thiodigalactoside dramatically reduces body weight gain in diet-induced obese rats.

Authors:  R Mukherjee; S W Kim; T Park; M S Choi; J W Yun
Journal:  Int J Obes (Lond)       Date:  2015-04-29       Impact factor: 5.095

2.  Galectin-3 inhibition prevents adipose tissue remodelling in obesity.

Authors:  E Martínez-Martínez; L Calvier; P Rossignol; E Rousseau; A Fernández-Celis; R Jurado-López; M Laville; V Cachofeiro; N López-Andrés
Journal:  Int J Obes (Lond)       Date:  2016-02-08       Impact factor: 5.095

3.  Galectin-3 maintains cell motility from the subventricular zone to the olfactory bulb.

Authors:  Isabelle Comte; Yongsoo Kim; Christopher C Young; Judith M van der Harg; Philip Hockberger; Paul J Bolam; Françoise Poirier; Francis G Szele
Journal:  J Cell Sci       Date:  2011-06-21       Impact factor: 5.285

4.  Increased levels of galectin-3 were associated with prediabetes and diabetes: new risk factor?

Authors:  H Yilmaz; M Cakmak; O Inan; T Darcin; A Akcay
Journal:  J Endocrinol Invest       Date:  2014-12-12       Impact factor: 4.256

5.  Relationship of galectin-3 with obesity, IL-6, and CRP in women.

Authors:  J Pang; V T Nguyen; D H Rhodes; M E Sullivan; C Braunschweig; G Fantuzzi
Journal:  J Endocrinol Invest       Date:  2016-07-21       Impact factor: 4.256

6.  CILAIR-Based Secretome Analysis of Obese Visceral and Subcutaneous Adipose Tissues Reveals Distinctive ECM Remodeling and Inflammation Mediators.

Authors:  Arturo Roca-Rivada; Susana Belen Bravo; Diego Pérez-Sotelo; Jana Alonso; Ana Isabel Castro; Iván Baamonde; Javier Baltar; Felipe F Casanueva; María Pardo
Journal:  Sci Rep       Date:  2015-07-22       Impact factor: 4.379

7.  Proteomics of old world camelid (Camelus dromedarius): Better understanding the interplay between homeostasis and desert environment.

Authors:  Mohamad Warda; Abdelbary Prince; Hyoung Kyu Kim; Nagwa Khafaga; Tarek Scholkamy; Robert J Linhardt; Han Jin
Journal:  J Adv Res       Date:  2013-03-26       Impact factor: 10.479

8.  Circulating Galectin-3 Is Associated With Cardiometabolic Disease in the Community.

Authors:  Matthew Nayor; Na Wang; Martin G Larson; Ramachandran S Vasan; Daniel Levy; Jennifer E Ho
Journal:  J Am Heart Assoc       Date:  2015-12-31       Impact factor: 5.501

9.  Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Alison C MacKinnon; Xiaojun Liu; Patrick Wf Hadoke; Mark R Miller; David E Newby; Tariq Sethi
Journal:  Glycobiology       Date:  2013-02-19       Impact factor: 4.313

10.  Increased adiposity, dysregulated glucose metabolism and systemic inflammation in Galectin-3 KO mice.

Authors:  Jingbo Pang; Davina H Rhodes; Maria Pini; Rand T Akasheh; Karla J Castellanos; Robert J Cabay; Dianne Cooper; Mauro Perretti; Giamila Fantuzzi
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.